|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
32
|
|
pubmed:dateCreated |
2009-11-9
|
|
pubmed:abstractText |
This multinational, double-blind, randomized, placebo-controlled, phase III trial assessed the efficacy and tolerability of the oral platinum analog satraplatin in patients with metastatic castrate-refractory prostate cancer (CRPC) experiencing progression after one prior chemotherapy regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BerryWilliamW,
pubmed-author:BodrogiIstvanI,
pubmed-author:CalabròFabioF,
pubmed-author:DemkowTomaszT,
pubmed-author:EymardJean-ChristopheJC,
pubmed-author:FalconSilviaS,
pubmed-author:FerreroJean-MarcJM,
pubmed-author:GeorgeMartineM,
pubmed-author:HarperPeterP,
pubmed-author:JamesNicholasN,
pubmed-author:McKearnThomas JTJ,
pubmed-author:NoursalehiMojtabaM,
pubmed-author:PetroneMichael EME,
pubmed-author:PetrylakDaniel PDP,
pubmed-author:RozencweigMarcelM,
pubmed-author:SartorOliverO,
pubmed-author:SternbergCora NCN,
pubmed-author:WirthManfredM,
pubmed-author:WitjesJ AlfredJA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5431-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19805692-Administration, Oral,
pubmed-meshheading:19805692-Adult,
pubmed-meshheading:19805692-Aged,
pubmed-meshheading:19805692-Aged, 80 and over,
pubmed-meshheading:19805692-Anemia,
pubmed-meshheading:19805692-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19805692-Constipation,
pubmed-meshheading:19805692-Diarrhea,
pubmed-meshheading:19805692-Disease Progression,
pubmed-meshheading:19805692-Double-Blind Method,
pubmed-meshheading:19805692-Drug Administration Schedule,
pubmed-meshheading:19805692-Humans,
pubmed-meshheading:19805692-Male,
pubmed-meshheading:19805692-Middle Aged,
pubmed-meshheading:19805692-Nausea,
pubmed-meshheading:19805692-Neoplasm Metastasis,
pubmed-meshheading:19805692-Orchiectomy,
pubmed-meshheading:19805692-Organoplatinum Compounds,
pubmed-meshheading:19805692-Prednisone,
pubmed-meshheading:19805692-Prostatic Neoplasms,
pubmed-meshheading:19805692-Survival Analysis,
pubmed-meshheading:19805692-Thrombocytopenia,
pubmed-meshheading:19805692-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.
|
|
pubmed:affiliation |
San Camillo and Forlanini Hospitals, Rome, Italy. cstern@mclink.it
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
